Biopharma / Medtech Reports

April 15, 2025

Rx Tariff Timing & Supply Chain Implications

•

John Leppard
April 14, 2025

Medtech & Medicare Inpatient Implications

•

John Leppard

ABT (US), BSX (US), DXCM (US), EW (US), MMSI (US), SIBN (US)
April 4, 2025

[NVO, LLY] No Medicare / Medicaid Coverage for Obesity Drugs

•

John Leppard

LLY (US), NVO (US)
March 31, 2025

Procept Biorobotics: Expecting ~20% Medicare Rate Cut

•

John Leppard

BSX (US), PRCT (US)
March 28, 2025

INSP, NYXH, LIVN: Sleep Apnea Coverage Timeline

•

John Leppard

INSP (US), LIVN (US), NYXH (US)
March 21, 2025

EXAS, GH: Colorectal Cancer Coverage in Hand, Edits to Come?

•

John Leppard

EXAS (US), GH (US)
March 20, 2025

EW, ABT: Tricuspid Replacement Coverage Benign

•

John Leppard

ABT (US), EW (US)
March 12, 2025

Guardant Health (GH): Next Steps on Shield

•

John Leppard

GH (US)
March 5, 2025

Life Science Tools: Court Intervention & NIH’s New Management

•

John Leppard

A (US), AVTR (US), BRKR (US), ILMN (US), MTD (US), QGEN (US), TMO (US), WAT (US)
March 3, 2025

[DXCM, OMI, AHCO] Glucose Monitors in the Crosshairs?

•

John Leppard

ABT (US), DXCM (US), OMI (US)